Depot buprenorphine injections for opioid use disorder: Patient information needs and preferences.
Joanne NealeCharlotte N E TompkinsJohn StrangPublished in: Drug and alcohol review (2019)
All potential patients should be offered accessible information on depot buprenorphine to enable them to consider their options and participate meaningfully in treatment decision making. We recommend that further qualitative research is undertaken to produce informative video material that describes patient experiences of receiving depot buprenorphine. This should help to balance biomedical knowledge with lay knowledge, so facilitating more informed discussions when decisions about depot buprenorphine treatment are made.